BiotechTube
Home/Cambridge Nucleomics/Dr Gerardo Patiño Guillén
DG

Dr Gerardo Patiño Guillén

Nanotechnology Lead

Cambridge Nucleomics

Therapeutic Areas

Infectious DiseaseOncology

Cambridge Nucleomics Pipeline

DrugIndicationPhase
Sepsis DiagnosticSepsis (Pathogen ID & AMR Profiling)Pre-clinical
Precision Oncology Liquid BiopsyEarly Cancer Screening & Circulating Tumor Biomarker DetectionExploratory

Leadership Team at Cambridge Nucleomics

DH
Dr Hendrik Runge
Founder & CEO
PU
Prof Ulrich Keyser
Scientific Founder
DA
Dr Anthony Cooke
Chairman
JY
John Yeomans
Director
DM
Dr Max Zhu, MBA
Director
DM
Dr Melanie Stammers
RNA Biology Lead
DR
Dr Rui Abreu Pereira
Microbiology Lead
View full Cambridge Nucleomics profile